Showing results (1491-1500 of 1,517) with videos related to

Sort By:
Pageof 152
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2021
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)Emmanuel Bachy, Vincent Camus, Catherine Thieblemont, et al.
Scientific Reports|July 15, 2020
MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemiaChih-Hsiang Yu, Tze-Kang Lin, Shiann-Tarng Jou, et al.
Rheumatology (Oxford, England)|August 12, 2022
Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in ChinaHanxiao You, Lei Wang, Jiajia Wang, et al.
Ebiomedicine|November 30, 2024
Homozygous variant in translocase of outer mitochondrial membrane 7 leads to metabolic reprogramming and microcephalic osteodysplastic dwarfism with moyamoya diseaseChia-Yi Li, Li-Wen Chen, Meng-Che Tsai, et al.
Human Molecular Genetics|April 17, 2010
Genome-wide association identifies ATOH7 as a major gene determining human optic disc sizeStuart Macgregor, Alex W Hewitt, Pirro G Hysi, et al.
Plos One|July 26, 2021
UV decontamination of personal protective equipment with idle laboratory biosafety cabinets during the COVID-19 pandemicDavis T Weaver, Benjamin D McElvany, Vishhvaan Gopalakrishnan, et al.
Nature Genetics|September 14, 2010
A genome-wide association study for myopia and refractive error identifies a susceptibility locus at 15q25Pirro G Hysi, Terri L Young, David A Mackey, et al.
In Vivo (Athens, Greece)|December 26, 2023
Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 PatientsPen-Hua Su, Ju-Shan Yu, Yu-Zhen Wu, et al.
Plos Genetics|June 12, 2012
Genetic variants on chromosome 1q41 influence ocular axial length and high myopiaQiao Fan, Veluchamy A Barathi, Ching-Yu Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2024
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP TrialVincent Camus, Catherine Thieblemont, Philippe Gaulard, et al.
Pageof 152